Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

trafermin

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Fibroblast Growth FactorPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal…
We investigated the efficacy, safety, and clinical significance of trafermin, a recombinant human fibroblast growth factor (rhFGF… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
Basic fibroblast growth factor combined with atelocollagen for closing chronic tympanic membrane perforations in 87 patients.
OBJECTIVE To present the clinical results of closing chronic tympanic membrane (TM) perforations using basic fibroblast growth… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero.
BACKGROUND Aplasia cutis congenita (ACC) is a condition in which localized or widespread areas of skin are absent at birth… Expand
Is this relevant?
2007
2007
Effect of basic fibroblast growth factor, trafermin, on entero-related fistulae, report of two cases.
Entero-related fistulae are often intractable. Recently, growth factors were generally in sight with the development of… Expand
Is this relevant?
2005
2005
Use of trafermin to treat a skin ulcer after repair of a deep auricular laceration: a case report.
We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that… Expand
Is this relevant?
2005
2005
The positive experience of using a growth factor product on deep wounds with exposed bone.
Trafermin, a form of basic fibroblast growth factor, has been used in Japan since 2001. This study investigates whether it can… Expand
Is this relevant?
2004
2004
030 Clinical Trials With Allogeneic Cultured Dermal Substitutes (CDS)(Regenerating Medical Millennium Project of the Ministry of Health, Labor and Welfare)
Aim: Clinical researches using allogeneic CDS, developed in the R & D Center for Artificial Skin of Kitasato University, have… Expand
Is this relevant?
2003
2003
A new method for closing tympanic membrane perforations using basic fibroblast growth factor.
OBJECTIVE To present a new method for closing tympanic membrane perforations using basic fibroblast growth factor (bFGF) combined… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Fiblast (Trafermin) in Acute Stroke: Results of the European-Australian Phase II/III Safety and Efficacy Trial
Background: Trafermin (basic fibroblast growth factor) has been shown to reduce infarct volume in acute ischemic stroke models… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1997
1997
Metabolism of the intravenously administered recombinant human basic fibroblast growth factor, trafermin, in liver and kidney: degradation implicated in its selective localization to the fenestrated…
The fate of trafermin (recombinant human basic fibroblast growth factor) was examined after intravenous administration of its… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE